MALAT1 was initially reported as an lncRNA that is highly expressed in stage I NSCLC tumors that subsequently metastasize, and high expression of MALAT1 is associated with short overall survival in patients with NSCLC [64]. This evidence concerns the gene MALAT1 and non-small cell lung carcinoma.